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Abstract
Cornelia de Lange Syndrome (CdLS) is the founding member of a class of multi-organ system birth defect syndromes
termed cohesinopathies, named for the chromatin-associated protein complex cohesin, which mediates sister chromatid
cohesion. Most cases of CdLS are caused by haploinsufficiency for Nipped-B-like (Nipbl), a highly conserved protein that
facilitates cohesin loading. Consistent with recent evidence implicating cohesin and Nipbl in transcriptional regulation, both
CdLS cell lines and tissues of Nipbl-deficient mice show changes in the expression of hundreds of genes. Nearly all such
changes are modest, however—usually less than 1.5-fold—raising the intriguing possibility that, in CdLS, severe
developmental defects result from the collective action of many otherwise innocuous perturbations. As a step toward
testing this hypothesis, we developed a model of nipbl-deficiency in zebrafish, an organism in which we can quantitatively
investigate the combinatorial effects of gene expression changes. After characterizing the structure and embryonic
expression of the two zebrafish nipbl genes, we showed that morpholino knockdown of these genes produces a spectrum
of specific heart and gut/visceral organ defects with similarities to those in CdLS. Analysis of nipbl morphants further
revealed that, as early as gastrulation, expression of genes involved in endodermal differentiation (sox32, sox17, foxa2, and
gata5) and left-right patterning (spaw, lefty2, and dnah9) is altered. Experimental manipulation of the levels of several such
genes—using RNA injection or morpholino knockdown—implicated both additive and synergistic interactions in causing
observed developmental defects. These findings support the view that birth defects in CdLS arise from collective effects of
quantitative changes in gene expression. Interestingly, both the phenotypes and gene expression changes in nipbl
morphants differed from those in mutants or morphants for genes encoding cohesin subunits, suggesting that the
transcriptional functions of Nipbl cannot be ascribed simply to its role in cohesin loading.
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Introduction
Cohesin is a multi-protein complex that associates with the
chromosomes of all eukaryotic cells, and mediates sister chromatid
cohesion, ensuring appropriate segregation of chromosomes during
cell division [1,2]. Recent work suggests that cohesin also acts
during interphase to regulate gene expression[3–5]. Studies on a set
of human birth defect syndromes recently termed ‘‘cohesinopa-
thies,’’alongwith workinDrosophilaand incellculture,point toroles
for cohesin in various processes such as long-range promoter/
enhancer communication, insulator action, and gene activation in
the presence of polycomb silencing activity (reviewed by [1]).
Many of these studies have focused on a protein known
variously as Scc2 (in yeast and Xenopus), Nipped-B (in Drosophila), or
Nipped-B-like (Nipbl, in most vertebrates), which is not itself a
cohesin subunit, but is required for the loading of cohesin onto
DNA [6–9]. Haploinsufficiency for NIPBL is the most frequent
cause of Cornelia de Lange Syndrome (CdLS) (OMIM #122470),
the most common of the cohesinopathies [10–13]. CdLS is a
multi-organ birth defects syndrome characterized by low birth
weight, short stature, and variably penetrant structural abnormal-
ities of the skeleton, heart, gut, kidney, genitalia, eyes, and teeth,
together with abnormalities in cognition and behavior [14–20]. A
recently developed mouse model of Nipbl haploinsufficiency
displays many of these abnormalities, along with nearly 80%
perinatal mortality [21]. Interestingly, in both man and mouse,
Nipbl heterozygotes show only a ,30% reduction in Nipbl mRNA
and protein [21–23], presumably a result of autoregulation of the
wild-type allele. This implies an extraordinary sensitivity of
developmental events to small changes in the levels of this
molecule. Indeed, clinical data suggest that a mere 15% decrease
in NIPBL levels produces a recognizable phenotype [22].
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Nipped-B expression have little or no effect on chromosome
cohesion [21,24–26] has led to the hypothesis that developmental
abnormalities in CdLS are the result of dysregulated gene
expression. Human and mouse studies indicate that hundreds of
genes are expressed abnormally in NIPBL/Nipbl/Nipped-B hetero-
zygotes in any given cell type or organ [21,23]. Yet with few
exceptions, the changes in gene expression are modest, nearly
always less than 2-fold, and typically less than 1.5-fold. Similarly
small changes in gene expression are seen in Drosophila and
mammalian cell lines when Nipped-B/NIPBL expression is
knocked down using RNAi [5,27]. Are such small effects, perhaps
collectively, the cause of pervasive developmental abnormalities?
Or are there some much larger effects of NIPBL deficiency on the
expression of critical developmental genes (cf. [27]) that have just
not yet been detected (e.g., because such genes are expressed at
early stages, for limited time periods, or in limited groups of cells)?
Answering this question is critical for more than just an
understanding of cohesinopathies and cohesin function: the
structural abnormalities in CdLS include some of the most
common, clinically significant, isolated (non-syndromic) birth
defects in humans, such as abnormalities of cardiac septum
development [15–17,28]. If such common defects can be reliably
caused by the collective actions of many small changes in gene
expression, it suggests a model for birth defects very different from
the single-gene-centered models that are supported by much of the
experimental literature.
To address this question definitively, one must be able to
manipulate Nipbl or cohesin levels and quantitatively monitor
phenotypic and gene expression changes from the earliest stages of
development. Here we achieve this goal in the zebrafish,
employing morpholino (MO)-mediated knockdown of Nipbl and
several of its putative targets. We find that Nipbl knockdown
produces heart, gut, and laterality defects with similarities to those
seen in CdLS. Analysis of gene expression suggests that early,
modest changes in expression of key regulatory genes involved in
endodermal differentiation, migration, and left-right (L/R)
patterning are likely to be the primary causes of such defects.
Quantitative analyses of the expression and functional knockdown
of two endodermal determinants, sox17 and foxa2, supports the
idea that developmental defects in CdLS can arise from the
synergistic effects of changes in expression of Nipbl target genes.
Results
Two Zebrafish nipbl Genes
BLAST searches using the amino acid sequence of human
NIPBL identified two zebrafish genes on chromosomes 10 and 5,
referred to as nipbla and nipblb, respectively. We cloned full-length
cDNAs for both from wild-type zebrafish (AB strain) by RT-PCR
and 59-RACE. The nipbla and nibplb cDNAs contained long open-
reading frames encoding proteins of 2,876 and 2,381 amino acids
in length, respectively (Figures 1A, S1). Predicted amino acid
sequences of Nipbla and Nipblb are 70% identical to each other
and 66% identical to that of human NIPBL. In both proteins,
highly conserved N-terminal and C-terminal regions (,200 and
,1,700 amino acids, respectively) flank a less-conserved central
region that is much shorter in Nipblb than in Nipbla (Figures 1A,B,
S1). Conserved HEAT domains, a putative nuclear localization
signal (NLS), and several protein-binding motifs (for SCC4 [9];
HDAC1/3 [29]; and HP-1 [30]), are also found in both proteins
(Figures 1A, S1).
Alignment with genome sequences revealed that nipbla and nipblb
contain 47 and 45 exons, respectively, and in each case the initial
ATG codon is located in exon 2. Exon-intron structure resembles
mammalian orthologs, though nipblb lacks one exon found in nipbla
and other orthologs, as well as the intron that separates exons 36
and 37. Both nipbl genes lie in genomic neighborhoods syntenic to
that surrounding human NIPBL: zebrafish orthologs of human
SLC1A3 (which encodes a high-affinity glutamate transporter),
LOC556181,a n dslc1a3a, lie upstream of nipbla and nipblb on
chromosomes 10 and 5, respectively. Other distantly related teleosts
such as medaka, Fugu, and stickleback also have two nipbl genes,
though one is much more similar to the two zebrafish Nipbls
(Figure 1C), raising the possibility that both zebrafish genes arose
from a single teleost duplicate.
Northern blot analysis revealed nipbla and nipblb transcripts of
approximately 10 and 8.5 kb, respectively (Figure 1D). Both are
detected in the early blastula, 2.5 h post fertilization (hpf, 256-cell),
before the onset of zygotic gene expression, and expression
progressively increases, reaching a peak at late gastrula stages (9
hpf, 90% epiboly), before decreasing by 26 hpf. While NIPBL
mRNAs of multiple sizes have been reported in human tissues
[11,13], transcripts of both zebrafish genes were detected as single
bands at all stages examined; this was confirmed using two
different probes against 59- and 39-ends (Figures 1D, S2). In situ
hybridization (ISH) revealed that both nipbla and nipblb are
expressed in similar spatiotemporal patterns (Figure 1E). Maternal
transcripts of both genes were detected throughout the blastoderm,
although staining was stronger for nipblb (consistent with the
Northern blotting results). Ubiquitous expression continues until
early somitogenesis (12 hpf), after which transcript levels gradually
decrease in the trunk (15–18 hpf), with strong expression becoming
restricted to the head by 25 hpf (Figure 1E). These expression
patterns are similar to those of cohesin subunits, smc3 [31] and
rad21 [32,33].
Requirements for nipbl Genes in Heart and Visceral Organ
Development
To analyze Nipbl function, we designed pairs of translation-
blocking morpholino antisense oligonucleotides (MOs) for nipbla
Author Summary
Although best known for its role in chromatid cohesion,
cohesin is increasingly seen as a regulator of gene
expression. In Cornelia de Lange Syndrome (CdLS), partial
deficiency for NIPBL, which encodes a cohesin regulator, is
associated with small changes in the expression of many
genes (similar effects are seen in Nipbl-deficient mice and
flies). Are such changes responsible for pervasive devel-
opmental defects in CdLS? To address this, we used
morpholino oligonucleotides to quantitatively reduce
levels of Nipbl protein and Nipbl target genes in zebrafish
embryos. Combined knockdown of both zebrafish nipbl
genes produced heart and gut defects with similarities to
those observed in CdLS. Nipbl-deficient embryos showed
quantitative changes in the expression of several genes
involved in the specification of endoderm, which both
gives rise to gut and provides a substrate for cardiac
precursor migration, as well as genes that regulate left-
right asymmetry. Functional studies of these putative
targets suggest that changes in their expression collec-
tively, and in some cases synergistically, contribute to the
observed phenotypes. These findings suggest that birth
defects in CdLS result from combinatorial, quantitative
effects of NIPBL on gene expression, and suggest that
cardiac and visceral organ defects in CdLS arise during
early embryonic development.
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target regions in the 59-UTR of each mRNA (see Materials and
Methods). To evaluate MO efficiency and specificity, we made
antibodies specific to Nipbla and Nipblb, and used them to
quantify protein levels by Western blotting. Both proteins were
detected at the predicted sizes, .300 kDa and 260 kDa,
respectively (Figure S3A). Injection of 0.5 ng/embryo of nipbla-
MO1 efficiently depleted Nipbla protein at 10 and 24 hpf, whereas
nipbla-MO2 was much less efficient (Figures 2A, S3B,D). Injection
of 0.5–1 ng of nipblb-MO1 partially depleted Nipblb protein at 10
hpf, but almost completely eliminated the protein by 24 hpf
(Figures 2A, S3B,C). Higher amounts of nipblb-MO1 did not
further deplete Nipblb protein at 10 hpf, nor did nipblb-MO2
(Figure S3B,D), even though both MOs were highly effective at 24
hpf (Figures 2A, S3C). As both MOs completely suppressed EGFP
expression when co-injected with nipblb-59-UTR-EGFP mRNA
(Figure 2B), the data suggest that, at 10 hpf, a substantial fraction
of Nipblb (but not Nipbla) is resistant to translational knockdown
(e.g., there may be a relatively stable pool of maternal Nipblb
protein).
Embryos co-injected with 0.75 ng each of 5-base mismatch
control MOs (referred to as ‘‘control’’ embryos below) to either
gene were indistinguishable from uninjected embryos (Figure 2C).
Embryos injected with either nipbla-MO1 (0.75 ng) alone (nipbla-
morphants) or together with nipblb-MO1 (0.75 ng; nipbla/b-
morphants) resembled controls at 18.5 hpf, but began to exhibit
defects by 24 hpf, including pericardial edema and a short tail
(Figure 2C). At 34 hpf, nipbla-morphants had more severe
pericardial edema (Figure 2C, asterisk) and no blood circulation
(52.7%, n=55) (Table S2). Some embryos had short tails, often
split or branched along the dorsal-ventral axis (49.1%), which
became more obvious at 52 hpf (Figure 2C, arrowheads). Embryos
injected with nipblb-MO alone (0.75 ng; nipblb-morphants) ap-
peared normal at 34 or 52 hpf, but co-injection of this MO with
nipbla-MO1 increased the percentage with pericardial and tail
defects (Figures 2C, S4B, Table S2). Some nipbla/b-morphants also
had defects in their urogenital openings at 52 hpf (10.0%, n=30)
(Table S2, Figure S4D). In addition, Alcian staining at 120 hpf
revealed changes in size, but not patterning, of most craniofacial
cartilages, with particularly severe reductions of the hyosymplectic
cartilage in the dorsal hyoid arch (pharyngeal arch 2; Figure S5).
Many nipbla/b-morphants had heart defects, as visualized by
ISH for a cardiac muscle marker, cmlc2, at 32 hpf (Figure 3A,
Table S2). These were classified into two types: Type A, abnormal
jogging/looping; and type B, defective cardiac precursor migra-
tion. Type A embryos (59% of nipbla/b-morphants) had beating
hearts but showed reduced or no jogging to the left (Figure 3B,
Table S2). Type B embryos (33% of nipbla/b-morphants) never
formed a midline heart tube, and nearly half exhibited cardia
bifida (Figure 3A–B, Table S2). This was not simply due to
delayed development of morphants, as similar phenotypes were
observed at 48 hpf (Table S2 and Figure S6A), and other
Figure 1. Zebrafish nipbl genes. (A) Domain structure of Nipbla and Nipblb proteins. N- and C-terminal conserved regions are shown in gray;
predicted domains and motifs as colored boxes. Pink lines indicate positions used for antisense RNA probes. (B) Comparison of Nipbl orthologs
among species. Numbers indicate amino acid identity to human NIPBL, as determined by Clustal W analysis (http://clustalw.ddbj.nig.ac.jp/top-j.html).
(C) Phylogenic tree of Nipbl proteins, constructed by the NJ method (http://www.ddbj.nig.ac.jp/), using full-length amino acid sequences from the
Ensembl database. (D) Expression of nipbla and nipblb mRNAs at 9 hpf was analyzed by Northern blotting (10 mg total RNA per lane) using DIG-
labeled antisense RNA probes. Two different probes for each gene (see panel A) were used. (E) Expression patterns analyzed by ISH with nipbla
(upper) and nipblb (lower) AS1 probes at indicated stages. Views are lateral, with anterior to the top (2.75–15 hpf) and left (18–35 hpf). Scale bar:
100 mm.
doi:10.1371/journal.pbio.1001181.g001
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the retina, occurred on schedule (Figure 3A). Similar heart defects
were also observed in nipbla single morphants but at lower
frequency (Table S2 and Figure 3B).
Because morphants with abnormal heart morphologies showed
circulation defects (Figure S7A), we examined development of
their blood/vascular system. O-dianisidine staining (which reveals
differentiated erythrocytes; Figure S7B–E) and ISH for gata1
(which labels erythrocyte precursors; Figure S7F,G) indicated that
erythrocytes form normally, but accumulate in the ventral tail.
Blood vessels, as marked by fli1a, are also specified normally in
morphants (Figure S7H,I). These data suggest that circulation
defects, and probably pericardial edema, in nipbla/b-morphants
are due to impaired heart function.
nipbla/b-morphants also displayed defects in the looping of gut
and visceral organs. ISH for the endodermal marker foxa3 revealed
a range of phenotypes, which we grouped into three classes (Types
I–III; Figure 3C). At 52 hpf, the gut normally loops leftward, and
liver and pancreas buds form on the left and right sides,
respectively. Of nipbla/b-morphants, 64.5% (n=96) had thin and
abnormally looped guts, and a smaller liver and pancreas (Type I;
Figure 3C). This included 38.5% with partial looping, 25% with
no looping, and 1% with reversed looping. In type II embryos
(11.5%), both the anterior gut and visceral organs were bifurcated
or duplicated bilaterally, whereas in type III embryos (18.9%), the
number of foxa3-expressing cells was severely reduced, and
anterior gut tubes did not form (Figure 3C). Similar heart and
visceral organ defects were also observed in embryos injected with
an independent set of MOs (nipbla-MO2 and nipblb-MO2),
although at lower frequency (Table S2).
nipbls Regulate Endodermal Gene Expression
To gain insight into the earliest effects of nipbl-depletion on gene
expression in the zebrafish embryo, we used microarrays to
analyze mRNA from uninjected and nipbla/b-morphant embryos
at early gastrula stages (6 hpf), hours before any morphological
phenotypes become visible (Table S3). Partial loss of Nipbl
function in mouse and man leads to many alterations in gene
expression, most less than 1.5-fold [21,23]. With effects in this
range, large sample sizes (10–20 independent samples for each
Figure 2. Morpholino knock-down of Nipbls. (A) Total protein lysates (10 embryos per lane) from uninjected embryos or embryos injected with
either 0.5 ng of nipbla-MO1 or 0.5 ng of nipblb-MO1 were prepared at 10 and 24 hpf and subjected to Western blotting with anti-Nipbla and Nipblb-
antibodies. Positions of Nipbla and Nipblb proteins are shown on the right. A lower band recognized by anti-Nipbla antibody (*) at 24 hpf is not
reproducibly observed and may be a degradation product of Nipbla. (B) Activities of nipblb-MOs at earlier stages. EGFP reporter RNAs (100 pg/
embryo)—nipbla-59-UTR-EGFP (upper panels) and nipblb-59-UTR-EGFP (lower panels)—were injected alone or together with either nipblb-MO1 or
nipblb-MO2 (1 ng/embryo), and EGFP fluorescence measured at 10–11 hpf. Views are lateral, with anterior and dorsal to the top and right,
respectively. (C) Morphology of living embryos at indicated stages. Uninjected embryos, control embryos co-injected with 0.75 ng each of two 5-mis-
nipbl-MOs, and embryos injected with either nipbla-MO1 (0.75 ng) or nipblb-MO1 (0.75 ng) alone or together (nipbla/b-morphants) are shown.
Pericardial edema and tail defects are indicated by asterisks and arrowheads, respectively. Views are lateral, with dorsal to the top. Scale bar: 100 mm.
doi:10.1371/journal.pbio.1001181.g002
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establish the significance of individual effects [21]. Due to sample
limitations, our studies were restricted to three independent pools
each of uninjected and morphant embryos. Therefore, we did not
seek to infer significance directly from the data, but rather used
them to generate ranked lists of candidate genes; up- or down-
regulation of these was subsequently tested by quantitative-RT-
PCR (Q-PCR). Thus, gene expression changes confirmed in the
present study are most likely a subset of those that actually
occurred.
As shown in Table S3, two known regulators of endoderm
development, sox17 and foxa2, appeared near the top of the list of
potentially down-regulated genes. Q-PCR confirmed that both
were significantly down-regulated by nipbla/b-MO1 even at
minimum doses of these MOs (0.5 ng each), as well as by nipbla/
b-MO2 (Figure 4A,B). The quantitative relationship between nipbla
MO1 dose and sox17/foxa2 reduction closely matched that
between MO dose and Nipbla protein level (Figure 4B).
Interestingly, the partial reduction in Nipblb protein caused by
injection of nipblb-MO1 at this stage did not have a significant
effect on the expression of these two endodermal genes, even in
nipbla-morphants.
During gastrulation, sox17 and foxa2 are expressed not only in
migrating endoderm, but also in dorsal forerunner cells (sox17) and
axial mesoderm (foxa2). At 6.5 hpf (Figure 4C) and 8.5 hpf (Figure
S8A), we consistently observed reduced expression of sox17 and
foxa2 by ISH in the endoderm of nipbla/b-morphants (Figure 4C,
arrows), but no significant change in their extra-endodermal
expression (arrowheads). Thus, nipbl levels specifically affect
endodermal expression of these genes.
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specification that begins with Nodal signaling [34,35]. They are
induced by a zebrafish-specific sox gene, sox32, which is essential
for the generation of endodermal cells [36–40]. We found that
sox32 expression was also decreased in the endoderm of nipbla/b-
morphants (Figure 4C), although less severely than sox17 or foxa2.
Two genes are known to lie upstream of sox32 in the endoderm
specification pathway, gata5 and bon [41]. By ISH, gata5 expression
was found to be slightly reduced at 6.5 hpf in nipbla/b-morphants
(Figure 4C), and more severely reduced at later stages (Figure
S8A); no change in bon expression was seen (Figure 4C). In
contrast, further upstream genes such as the Nodal-relative cyclops
(cyc) and the essential Nodal receptor co-factor one-eyed-pinhead (oep)
as well as genes involved in mesodermal development (no tail, ntl;
even-skipped-1, eve1; and T-box gene 16, tbx16) or expressed
ubiquitously (ribosomal protein L13a, rpl13a and POU domain class 5
transcription factor 1, pou5f1) were all normally expressed in nipbla/b-
morphants (Figure S8B,C). Nodal targets were also not among
those conspicuously altered in expression in the microarray studies
(Table S3).
We next sought to determine whether the decrease in expression
of sox17 and foxa2 in nipbla/b-morphants is a direct effect of
reduced Nipbl function, or is indirectly mediated by the reduction
in sox32 expression. Sox32 lies upstream of sox17 and foxa2 in two
distinct ways. First, Sox32 is required for endoderm specification,
so that reduced sox32 expression might lower sox17 and foxa2 levels
simply by depleting the cells that transcribe these genes. Second,
Sox32 is a direct transcriptional activator of sox17 and foxa2.T o
test whether the changes in expression of sox17 and foxa2 in nipbla/
b-morphants could be accounted for by either of these explana-
tions, two types of experiments were done.
First, we directly counted endodermal cells at late gastrula stages
in control and nipbla/b-morphant embryos (Figure 4D). Using
sox32 ISH as a marker, we observed a 58% decrease in
endodermal cells. However, using either sox17 or foxa2 as markers,
the numbers of endodermal cells that could be visualized were
significantly lower (68%–69%, p,0.001). These results suggest
that endodermal depletion contributes to, but is only part of the
explanation for, the overall reduction in sox17 and foxa2
expression.
Second, we directly analyzed the transcriptional regulation of
sox17 and foxa2 by Sox32 in controls and nipbla/b-morphants
(Figure 5A–D). In one set of experiments, we measured the dose-
dependence of induction of sox17 and foxa2 in response to injected,
exogenous sox32 mRNA. For any gene that Nipbls influence solely
via the indirect effect of altering sox32 levels, we would expect to
see an identical dose-response relationship, with respect to total,
measured Sox32 level, in both controls and morphants (Figure 5A,
left panel). For cxcr4a, this is indeed what was observed (Figure 5B).
In contrast, for sox17 and foxa2, the dose-response curves were
shifted downward in nipbla/b-morphants (Figure 5C,D). This
implies a Nipbl-sensitive input to the expression of these genes,
independent of the effect of the level of sox32 (Figure 5A, right
panel). In a second set of experiments, we effectively removed
endogenous Sox32 with a sox32-MO, and replaced it with an
exogenous sox32 mRNA that lacked the MO-binding site (sox32-
9mis) (Figure 5E,F). As expected, injection of the sox32-MO
significantly reduced expression of sox17, foxa2, and cxcr4a, and this
could be restored by co-injection of sox32-9mis mRNA. For cxcr4a,
rescue of expression by sox32-9mis mRNA occurred to about the
same degree in nipbla/b-morphants and control embryos. In
contrast, for sox17 and foxa2, exogenous sox32 mRNA restored
gene expression about half as well in nipbla/b-morphants as in
controls (Figure 5F). These results imply that Nipbls influence the
responsiveness of sox17 and foxa2 to transcriptional activation by
sox32. Although it is possible that this effect reflects an influence of
Nipbls on the expression of some transcriptional co-regulator of
sox17 and foxa2, the only other well-characterized activator of
sox17 in zebrafish is Pou5f1/Oct4 [42–44], and neither microarray
analysis (Table S3) nor Q-PCR (Figure S8C) showed a change in
pou5f1 levels in nipbla/b-morphants. Thus, Nipbls may act directly
upon sox17 and foxa2.
Functional Consequences of Altered Endodermal Gene
Expression
Although the heart and gut derive from different germ layers
(mesoderm and endoderm, respectively), Nipbls could regulate
their development through common mechanisms. For example,
mutations that affect early L/R patterning can cause defects in the
looping of both heart and gut tubes [45–47], while mutations that
affect early endoderm can severely disrupt medial migration of
cardiac progenitors (which use the endoderm as a migratory
substrate), leading in some cases to cardia bifida [36,38,48].
Interestingly, we observed that most morphants with type A
heart jogging/looping defects later displayed type I gut looping
defects (Figure S9A), consistent with both being caused by a
common abnormality of L/R patterning. Similarly, most mor-
phants with type B heart fusions, including those with cardia
bifida, later displayed type III gut defects (Figure S9A), consistent
with both types arising from a deficiency in early endoderm. This
idea was further supported by the fact that type A and type B heart
phenotypes were obtained at doses of nipbla-MO similar to those
that caused type I and type II/III gut phenotypes, respectively
(Figure S9B–D). Type B heart and type II/III gut phenotypes
required at least 0.25 ng of nipbla-MO1 (Figure S9C,D), similar to
the doses required for endodermal gene expression defects
(Figure 4B). In contrast, looping defects were more sensitive to
small changes in Nipbla protein levels (Figure S9C,D), as were
circulation and tail defects (Figure S9E).
To test the hypothesis that endoderm deficiency is the cause of
type B heart and type III gut phenotypes in nipbla/b-morphants,
we attempted to rescue these defects by expressing exogenous gata5
or sox32 mRNA, which increases the number of endodermal cells
in the gastrula-stage embryo [36,37,48]. At low levels of gata5 or
sox32 mRNA expression, which did not themselves cause
substantial heart or gut phenotypes, we observed marked rescue
of both type B heart, and type III gut, phenotypes, but no
significant rescue of type A (heart) or type I (gut) phenotypes
nipblb-MO1 alone, or with a mixture of 0.5 ng each of nipbla-MO1 and nipblb-MO1 (purple). (C) Analysis of endodermal gene expression by ISH.
Control embryos (upper) and nipbla/b-morphants (lower) were analyzed at 6.5 hpf with sox17, foxa2, sox32, gata5, and bon Probes. Expression of all
except bon was markedly (sox17, foxa2) or weakly (sox32, gata5) reduced in endoderm cells (arrows) of nipbla/b-morphants, but not in dorsal
forerunner cells (sox17 and sox32; arrowheads) or axial mesoderm (foxa2; asterisks), and this is more clearly shown in higher magnification panels of
sox17 expression at dorsal marginal regions. Views are lateral, with dorsal to the right, except the higher magnification panels (dorsal view, with
anterior to the top.). Scale bar: 50 mm. (D) Endodermal cells, as detected by ISH with sox32, sox17,o rfoxa2 probes, were counted in uninjected
embryos (black) and nipbla/b-morphants (red) at 8.3 hpf (80% epiboly). The bar graph expresses the data relative to average numbers in uninjected
embryos (mean 6 SD; * p,0.001). The table underneath presents the average numbers of endodermal cells per embryo, along with the number of
embryos counted (in parentheses).
doi:10.1371/journal.pbio.1001181.g004
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Figure 5. Multiple modes of regulation of sox17 and foxa2 by nipbls. (A–D) Embryos were injected with increasing (3.125–25 pg) amounts of
in vitro synthesized sox32 mRNA, and either 5-mis-nipbl-MO1 mixture (0.75 ng each: control) or nipbl-MO1 mixture (0.75 ng each: nipbla/b-MO1).
mRNA levels for the sox32-target genes sox17, foxa2, and cxcr4a were quantified at 6.5 hpf by Q-PCR, normalized to ef-1a, and expressed relative to
levels in embryos not treated with exogenous sox32 mRNA. As sox32 induces its own expression [38], target gene expression was determined as a
function of total sox32 (endogenous and exogenous, both measured directly), and not just the amount of sox32 RNA injected. (A) Top: expected
behavior of a sox32 target gene that is not itself affected by nipbls. The same relationship between sox32 level and target gene expression should be
observed in control and nipbla/b-morphant embryos. Right: expected behavior of sox32 target gene that is independently acted upon by nipbls
(either directly, or because nipbls control the expression of other inputs to the gene). In this case, the relationship between sox32 level and target
gene expression will be shifted in nipbla/b-morphant embryos. (B) cxcr4a displays the expected behavior of a sox32 target gene that is not itself
affected by nipbls. (C,D) sox17 and foxa2 display the expected behavior of sox32 target genes that are independently sensitive to nipbl function. In
panels B–D, data are presented as mean 6 S.E.M (n=3). Dose-response relationships were well fit by straight lines (least-squares regression yielded
values of r
2.0.95 in all cases). (E, F) To eliminate any indirect effects of Nipbl reduction on gene expression through sox32, endogenous Sox32 protein
was removed with a sox32-MO (5 ng) and replaced with sox32-9mis mRNA (10 pg), lacking the MO binding site for sox32-MO, and endodermal gene
expression was examined by Q-PCR. (E) Embryos coinjected with sox32-MO and either a wild-type sox32(WT)- or mutated sox32(9mis)-GFP reporter
construct show that a 9-base-mutation is sufficient to escape suppression of translation by sox32-MO. Lateral views at 12 hpf. Scale bar: 100 mm. (F)
Effects of Nipbl reduction on expression of endodermal genes (sox17, foxa2, and cxcr4a) were examined in control (blue, red), Sox32-deficient (MO;
green, orange), and Sox32-restored (MO+mRNA; light blue, pink) embryos at 7 hpf (n=4, mean 6 S.E.M.; * p,0.01 and ** p,0.03 by paired t test).
The data show that induction of sox17 and foxa2 by exogenous Sox32 is markedly Nipbl-dependent, whereas induction of a different Sox32 target,
cxcr4a, is not.
doi:10.1371/journal.pbio.1001181.g005
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gut phenotypes in nipbla/b-morphant phenotypes have a common
origin in reduced endodermal cell production or survival.
Interestingly, the type II gut phenotype (bifurcation with visceral
organ duplication) was also partially rescued by exogenous gata5
and sox32 (Figure 6B). Gut/visceral organ duplication can arise
from delayed medial migration of endoderm [49,50]. Moreover, in
mice, anterior gut duplications can be caused by loss of Foxa2
[51,52]. In zebrafish, however, gut defects have not been reported
in foxa2 mutants [53], but foxa2 morphants do show subtle
morphological changes in the liver and pancreas [54]. Upon
repeating such studies, we observed a type II phenotype in a small
proportion of foxa2-morphants (7%; Figure 6C). We also observed
a type II phenotype in a small proportion (5%, Figure 6C) of
sox17-morphants (sox17 knockdown has not previously been
reported, Figure S10). Intriguingly, when sox17 and foxa2 were
knocked down simultaneously, the fraction of embryos displaying
gut/visceral organ duplication rose to nearly 60% (Figure 6C). Yet
even in such embryos, the sizes of liver and intestine were normal,
or only slightly reduced (Figure 6D), in contrast to the marked
reductions seen in most nipbla/b-morphants (Figure 3C). Thus,
reduced expression of sox17 and foxa2 can synergistically reproduce
most, but not all, aspects of the type II phenotype.
Requirements for nipbls in Expression of Genes Involved
in Left-Right Asymmetry
In contrast to other phenotypes, looping defects in heart (type A)
and gut (type I) tubes were not significantly improved by
expressing gata5 and sox32 (Figure 6A,B). Since, as mentioned
above, these phenotypes could be caused by global defects in
laterality, we examined expression of genes involved in L/R
patterning [46,47,55,56]. At 18 hpf, expression of the nodal-related
gene southpaw (spaw) is normally restricted to the left lateral plate
mesoderm (LPM) along the midline, as well as to a region adjacent
to Kupffer’s vesicle (KV), a structure involved in the initiation of
L/R asymmetric patterning (Figure 7A) [57,58]. In nipbla/b-
morphants, spaw expression in LPM was severely reduced
(Figure 7C) or present on both left and right sides (Figure 7D);
in both cases, expression around KV was reduced (Figure 7C,D).
A second nodal relative, lefty-2, is downstream of spaw [56] and is
normally expressed in left LPM in the heart region at 21.5 hpf
(Figure 7E). In nipbla/b-morphants, its expression was also severely
reduced (Figure 7G) or lost (Figure 7H). Ectopic (right-sided) lefty-2
expression was also observed in a small number of the morphants
(Figure 7I).
The expression of spaw in left LPM is induced by signals from
KV [58], and inhibited by the Cerberus-related protein Charon
[59]. Although we did not observe morphological abnormalities in
KV, or in charon expression (Figure 7J–M), expression of dynein,
axonemal, heavy polypeptide 9 (dnah9) was markedly reduced in most
nipbla/b-morphants (Figure 7N–P). dnah9 encodes a motor protein
required for motility of monocilia in the KV, and its loss is known
to impair KV fluid flow and disrupt L/R development [58]. This
result suggests that Nipbls may act on L/R patterning by
controlling KV function. On the other hand, the fact that the
phenotypes of nipbla/b-morphants and dnah9-morphants are
qualitatively different—dnah9 has more of an effect on the
sidedness, than the level, of lefty-2 and spaw expression [58],
whereas for nipbls, the opposite appears to be the case (Figure 7)—
also raises the possibility that Nipbls exert later, more direct effects
on the expression of left-side-specific genes. Consistent with this
possibility, both nipbla and nipblb expression was detected in cells
around KV and in LPM (both sides) at 14 hpf (10-som) and 20 hpf
(22-som), respectively (unpublished data).
Effects of Nipbl Deficiency Are Distinct from Those of
Cohesin Deficiency
Nipbl/nipped-B/Scc2 was initially characterized as a cohesin-
loading factor, and localizes extensively with cohesin on
chromosomes (e.g., [60]). Whereas NIPBL mutations are respon-
sible for more than half of CdLS cases, recent work has shown that
CdLS can also be caused by mutations in the genes encoding
cohesin subunits Smc1 and Smc3 [61,62]. These and other
findings suggest that Nipbl and cohesin work together in regulating
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Figure 6. Nipbls affect gut and heart development through
regulation of endodermal gene expression. (A, B) Exogenous
gata5 and sox32 rescue a subset of gut and heart defects in nipbla/b-
morphant embryos. mRNAs for gata5 (10 pg) or sox32 (2.5 pg) were
injected into control embryos (no MO; left 3 columns) or nipbla/b-
morphants (right 3 columns), and heart (A) and gut (B) morphologies
were examined by ISH with cmlc2 (32 hpf) and foxa3 (52 hpf) probes,
respectively. Numbers of embryos examined are shown at the top. (C,
D) Gut bifurcation, similar to the type II gut phenotype found in nipbla/
b-morphants, was induced by simultaneous reduction of sox17 and
foxa2. (C) Frequency of gut bifurcation in sox17 and foxa2-single and
double-morphants at 52 hpf. (D) Gut/visceral organ morphologies
analyzed by ISH with foxa3 probe. View is dorsal, with anterior to the
top. Scale bar: 50 mm.
doi:10.1371/journal.pbio.1001181.g006
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mutation and/or morpholino knockdown of cohesin function in
the zebrafish produces a variety of gene expression changes, with a
phenotype characterized by loss of expression of runx3, loss of
hematopoietic expression of runx1, and concomitant lack of
development of differentiated blood cells [32,65].
To address whether developmental effects caused by nipbl
deficiency in the zebrafish could be explained by impaired cohesin
function, we examined the effects of knocking down expression of
cohesin subunit genes smc3 and rad21 (Figure 8) [31,65].
Remarkably, expression of the endodermal genes sox32, sox17,
and foxa2—which are markedly affected in nipbla/b-morphants—
was unchanged in smc3 or rad21 morphants (Figure 8A,B), even at
levels of MO that produced substantial reduction in cohesin
protein level (Figure 8C) and caused gross morphological
abnormalities (Figure 8D). Conversely, upregulation of p53 and
mdm2, which occurs in smc3- and rad21-morphants (Figure 8B;
[65]), was not seen in nipbla/b morphants. For some genes,
including myca, ascl1a, and ascl1b, expression was reduced in both
types of morphants (Figure 8B).
Both p53 and mdm2 are known to be induced by a range of
physiological stresses [66], suggesting that their differential
induction in cohesin (smc3 or rad21)- and nipbla/b-morphants
might be due to different levels of overall phenotypic severity (and,
thus, non-specific stress) in the two situations. To investigate this
possibility, we injected lower amounts (0.75 ng/embryo) of smc3-
MO (Figure S11A, low-smc3-morphants) and examined gene
expression (Figure S11B). At levels at which reduction of both
gross morphology and ascl1a and ascl1b expression were compa-
rable between these and nipbla/b-morphants, induction of p53 and
mdm2 was still much higher in the smc3-morphants, suggesting
specific regulation by cohesin. These results, together with the
observation that blood cells develop normally in nipbla/b
morphants (Figure S7), suggest that nipbl and cohesin have
overlapping, but distinct, influences on gene expression.
Discussion
Zebrafish as a Model Organism for the Study of CdLS
Here we characterize the zebrafish nipbl genes, and show that
nipbl-morphant zebrafish display multiple abnormalities in early
heart and gut/visceral organ development (Figure 3). These
changes are preceded by reduced expression of genes required for
endoderm formation and function, and L/R patterning, both
processes being critical for normal heart and gut development
(Figures 4,7; Table S2). We demonstrate that at least some of the
observed gene expression changes are sufficient, collectively, to
produce a subset of the observed morphological abnormalities
(Figure 6C,D). These results indicate that heart and gut/visceral
organ deficits arise in the context of both abnormal endoderm
development and abnormal L/R patterning (Figure 9).
The parallels between nipbl-morphant phenotypes and the birth
defects in CdLS [16] are striking. Heart and gut abnormalities are
prominent in CdLS, and among the primary causes of morbidity
and mortality [16,17,67]. Marked L/R asymmetry in the severity
of defects in CdLS (e.g., in limbs; [17]), together with the
occurrence of intestinal malrotation [16], suggest that overall L/R
patterning is also disturbed in this syndrome. Gut duplications,
which are sometimes observed in nipbl-morphant fish (Figure 3,
Table S2), are also seen, rarely but significantly, in CdLS [68,69].
As in CdLS, and in Nipbl-heterozygous mice [21], Nipbl-deficient
fish also exhibit growth retardation and distinctive craniofacial
abnormalities (Figures 2C and S5), the latter including severe
reductions of the hyosymplectic cartilage, the homologue of the
mammalian stapes [70]. Abnormal development of the stapes and
other middle ear bones is reported in CdLS [71], and our results
suggest that defects in embryonic development of the precursors of
these bones could account for some aspects of hearing loss in
CdLS [16,17] and in Nipbl-heterozygous mice [21].
Notwithstanding some major anatomical differences between
fish and mammals (e.g., fish hearts are not divided by septa), these
results suggest that developmental alterations caused by Nipbl
deficiency in zebrafish may provide mechanistic insight into the
origins of human birth defects. For example, the results
immediately raise the possibility that heart and gut defects in
CdLS originate during gastrulation, much earlier than might have
been suspected from the times at which structural abnormalities
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Figure 7. L/R patterning defects in nipbla/b-morphants. Left-
sided expression of spaw (n=38) and lefty2 (n=60) in lateral plate
mesoderm (LPM) is disrupted in nipbla/b-morphants. (A–D) At 18 hpf
(18-somite), spaw expression (red arrows) was variably unchanged (B;
47.4% of embryos), absent (C; 39.4%), or bilateral (D; 13.2%). The
midline is marked by a dotted line. Insets show bilateral expression of
spaw in the tail-bud. (E–I) lefty2 expression at 21.5 hpf (25-somite) was
either unchanged (F; 34.9%), reduced (G; 33.3%), absent (H; 25.4%) or
right-sided (I; 6.3%). Views are dorsal, anterior to the top. (J–M)
Morphology of Kupffer’s vesicle (J, K; arrowheads; bright-field micros-
copy) and charon expression (L, M; ISH; posterior views of tail regions)
are similar in control and nipbla/b-morphants at 16 hpf (14-somite). (N–
P) Expression of dnah9 in dorsal forerunner cells (arrows) at 8.3 hpf (80%
epiboly) is reduced in nipbla/b-morphants (O, P) relative to controls.
Views are dorsal, anterior to the top. Scale bars: 50 mm.
doi:10.1371/journal.pbio.1001181.g007
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morphant zebrafish may provide such a good model for CdLS is
that the early insensitivity of nipblb to MO-mediated knockdown
(Figures 2, S3) may fortuitously make the total decrease in Nipbl
function in nipbla/b-morphant embryos approximate what occurs
in human and murine NIPBL-haploinsufficiency [21,23]. This
view is supported by data suggesting that Nipbla and Nipblb have
similar functions, e.g. knockdown of nipblb in nipbla-single
morphants increases the frequency of heart defects. Yet the fact
that Nipblb reduction does not also increase the frequency of
endodermal gene expression defects suggests that some functional
differences exist between the two genes.
Despite the fact that, at late stages, both Nipbla and Nipblb
proteins were strongly reduced in nipbla/b-morphants, their
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morphants, suggesting that only trace amounts of Nipbls are
sufficient to maintain normal chromosomal cohesion. Consistent
with this view, nipbla/b-morphants display at most a small increase
in premature sister chromatid separation (unpublished observa-
tions), similar to what is seen in NIPBL-heterozygous human and
mouse cells [21,23,25].
Regulation of Gene Expression by nipbls
It is rapidly emerging that Nipbl and cohesin play global, if still
poorly understood, roles in the regulation of gene expression (e.g.,
[1,5,21,23,27,72–74]). In human, mouse, and fly cells, partial
reduction in NIPBL/Nipped-B function produces modest changes in
the expression of large numbers of genes [21,23,27]. In nipbla/b-
morphant zebrafish, we also observed modest changes in the
expression of multiple zygotic genes (Figures 4,7,S8; Table S3).
Because these changes were detected at early gastrula stages—only
hours after the onset of zygotic transcription—the probability that
some of them are directly caused by reduced Nipbl function
should, a priori, be greater than in studies using other organisms, in
which many gene expression changes could be secondary effects of
other gene expression changes. Interestingly, a subset of the genes
identified by microarray experiments as potentially affected by
Nipbl depletion in zebrafish (Table S3) also show changes in Nipbl
heterozygous mouse fibroblasts (pitx2, cebpd, jag1 [21]), embryonic
mouse brain (alcam, cnot8, cxcl12, hlcs, myc, neo1, nos1, notch2, vldlr
[21]) or human lymphoblastoid cells (alcam, myc, bmi1, ctage5, id3,
nsun2, pccb, psme1, ptma, rab2a, robo1, rora, sfrs1, snrp70, snx3, ube2g1
[23]). Whether such overlap is functionally significant is difficult to
assess given the different tissues and stages examined in different
organisms.
Interestingly, we found some of the genes dysregulated in nipbl-
morphants to be members of known gene-regulatory networks:
e.g., gata5, sox32, sox17, and foxa2, controlling endoderm
development; and dnah9, spaw, and lefty2, controlling L/R
patterning. By examining the effects of graded sox32 misexpression
as well as replacement of endogenous with exogenous Sox32, we
showed that changes in sox17 and foxa2 expression due to Nipbl
deficiency are only partially explained by altered levels of sox32,
their common upstream activator (Figures 4–5), and presented
evidence that Nipbls influence the transcriptional responsiveness of
sox17 and foxa2. Consistent with this, preliminary chromatin
immunoprecipitation studies suggest that Nipbla binds near the
transcriptional start site of sox17 (unpublished observations).
Whether Nipbls regulate responsiveness of sox17 and foxa2 solely
to Sox32, or to other transcriptional effectors as well, is not known,
but specificity is suggested by the fact that extra-endodermal
patterns of expression of sox17 and foxa2 are largely insensitive to
Nipbl depletion (Figures 4C, 7A). foxa2 expression in floor plate,
for example, is regulated by Nodal and Shh, but independent of
Sox32 [53], and is normal in nipbla/b-morphants (Figure S8 and
unpublished observations).
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Figure 9. Multiple influences of Nipbls on regulatory networks underlying heart and visceral organ development. Endoderm
development is initiated by Nodal-dependent activation of a network of transcription factors. Within this network, Nipbls regulate expression of
gata5, sox32, sox17, and foxa2. Sox32 is required for specification and maintenance of endoderm cell fate, and reduced levels of Sox32 in nipbla/b-
morphants may reduce endodermal cell number. This, in turn, could produce in a thinner gut, and smaller visceral organs, as well as a failure of
cardiac progenitors that migrate along endoderm to form a midline heart tube. In parallel, a network triggered by cilia-driven fluid flow in KV
underlies the establishment of L/R asymmetry in the embryo. Within this network, Nipbls regulate expression of dnah9, as well as the asymmetric
expression of spaw and lefty2. Disruption in the expression of these genes is likely to underlie the heart jogging/looping, and gut looping defects in
nipbla/b-morphants.
doi:10.1371/journal.pbio.1001181.g009
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currently unknown. Drosophila Nipped-B and cohesin occupy largely
overlapping sites in the genome [60]. In mammalian cells, most
cohesin localizes to binding sites for the insulator protein CTCF,
which requires cohesin for function [75–78], but a recent study of
mammalian cells [5] indicates that Nipbl preferentially occupies
non-CTCF sites at promoter regions, at which complexes exist
between cohesin and the Mediator complex (which mediates
transcriptional transactivation). Our finding that nipbl-knockdown
and cohesin-knockdown produce distinctive phenotypic and gene-
expression effects in the zebrafish (Figure 8) strongly suggests that
only some of the functions of Nipbl are attributable to a general role
in promoting cohesin function. In Drosophila, manipulation of
Nipped-B and cohesin expression has also been observed to have
overlapping, different, or even opposite effects, depending upon the
experimental circumstances [24,27,64]. In man, the mild forms of
CdLS that have been linked to mutations in cohesin subunit genes
(Smc1 and Smc3 [61,62]) appear to be caused by specific, rare
missense mutations (i.e., very likely not simple loss-of-function
alleles), also consistent with the idea that the cause of CdLS is not
simply a reduced level of cohesin function, but rather the selective
disruption of specific functions in which Nipbl and cohesin work
together. Such functions could be related to the ability of Nipbl to
interact directly withmolecules such as histone deacetylases, HP-1c,
and chromatin remodeling factors (e.g., [29,30,79]). Indeed, given
its large size and conserved, multi-domain structure, it may turn out
to be more appropriate to envision Nipbl as a cohesin-associated
scaffold protein, rather than a cohesin-loading factor.
From Gene Expression to Developmental Phenotypes
Endoderm development and L/R patterning are crucial events
in normal heart and gut development (Figure 9), and both are
clearly affected in nipbla/b-morphants. Endoderm development
appears to be impaired at more than one level, consistent with
altered expression of multiple genes (sox32, sox17, foxa2, gata5)i n
the pathway controlling early endoderm specification and
formation of the gut. Previous work suggests that gata5 and sox32
are required for specification of endodermal cell fates, whereas
sox17 and foxa2 act downstream at the level of endodermal
differentiation [37–39,41,48]. We hypothesize that reduced gata5
and/or sox32 expression is the cause of type III gut phenotypes
(reduced gut/visceral organ tissue) in nipbla/b-morphants; consis-
tent with this, injection of exogenous gata5 or sox32 mRNA rescues
this phenotype (Figure 6B). A defective urogenital opening—which
is also seen in nibpla/b-morphants (Figure S4)—is also a known
consequence of a deficiency of endoderm [36,80].
Exogenous gata5 and sox32 mRNA also rescued type B heart
phenotypes (failure to form a normal midline heart tube; Figures 6A,
S6), consistent with the known dependence of cardiac progenitor
migration ontheendoderm.Moreover, most aspects ofthetype II gut
phenotype (anterior bifurcation/duplication) were efficiently pro-
duced by simultaneous MO-knockdown of sox17 and foxa2
(Figure 6C,D). These results are consistent with sox17 and foxa2
acting downstream of endoderm specification to influence endoder-
mal cell behaviors, such as migration (Figure 9). In contrast, defects in
nipbla/b-morphants characterized by abnormal or reversed looping
(type I gut and type A heart defects) were not significantly rescued by
gata5 or sox32 mis-expression, and only weakly reproduced by
combined sox17/foxa2 knockdown (Figure 6 and unpublished data).
Given the nature of these phenotypes, we suspect they are primarily
caused by a common defect in L/R patterning (Figure 7).
Interestingly, these different phenotypes correlate with different
degrees of depletion of Nipbla protein levels; i.e., endoderm-related
(type B heart and type II/III gut) phenotypes require more
significant reduction of Nipbla protein than L/R patterning-related
(type A heart and type I gut) phenotypes (FigureS9).However, since
we examined protein levels in whole embryos, we cannot exclude
the possibility that effectsof MO on protein levels differ between cell
types, and a higher amount of nipbla-MO may be required for
significant reduction of Nipbla protein levels in endodermal cells.
Taken together, our findings imply a mechanistic model in which
reduced Nipbl function has modest, quantitative effects on the
expression of multiple genes; some of these changes lead to
quantitative functional deficits; and these in turn contribute
collectively to the appearance of developmental defects (Figure 9).
For at least one set of genes (sox17 and foxa2), the mode of gene
interaction is synergistic; i.e., quantitative alterations in the levels of
both genes seem to be necessary to produce at leastone aspectof the
nipbl-morphant phenotype (Figure 6C). If phenotypes in nipbl-
morphant zebrafish are indeed explained by the cooperative effects
of quantitative changes in gene expression, it not only provides a
framework for understanding specific classes of birth defects
syndromes, such as CdLS and the cohesinopathies; it also suggests
a mechanism by which non-syndromic birth defects (which are far
more common) might naturally arise out of combinations of
quantitative genetic variants in the human population.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
University of California, Irvine Institutional Animal Care and
Use Committee.
Fish Maintenance and Embryo Raising
Zebrafish (AB strain) were maintained and staged as described
[81,82].
Cloning of Full-Length cDNA of nipbla and nipblb
By searching Genbank and Sanger DNA/protein databases
using the human NIPBL protein sequence, we found entries for
nipbla and nipblb genes. Although the Ensembl database had only
partial sequences for both genes (ENSDART00000086861 and
ENSDART00000086653 [nipbla]; ENSDART00000111663 and
ENSDART00000108661 [nipblb]), these differed from those in the
NCBI database (XM_001919812 [nipbla]; XM_001920168
[nipblb]) even within overlapping regions. We therefore cloned
and sequenced cDNAs for both genes by RT-PCR, using cDNA
from wild-type zebrafish embryos (9 hpf). cDNA fragments
containing 59-UTR were amplified by 59 RACE, subcloned into
the pCRII-TOPO vector (Invitrogen), and sequenced.
Microinjection of Morpholino Antisense Oligo and mRNA
Morpholino antisense oligos (MO) were designed to block
translation or splicing (Gene Tools, Inc.) including: nipbla-MO1, 59-
ACGTGGACGCACAGGTTGCTCAGTG-39; nipbla-MO2, 59-T-
CGCTGCTCACTGATCCACCTTTAC-39; nipblb-MO1, 59-TG-
ACGGCTGGGCACAGAAGTCTAAC-39; nipblb-MO2, 59-GCA-
CACAGAGATCCACAGAGATATT-39;5 mi s - nipbla-MO1,59-AC-
cTcGACGgACAGcTTcCTCAGTG-39;5 m i s - nipblb-MO1, 59-TG-
ACGcCTcGGCAgAGAAcTgTAAC-39; sox17-MO, 59-CCATGA-
CTTACCTATAAACAGAACA-39; foxa2-MO, 59-CCTCCATT-
TTGACAGCACCGAGCAT-59 [53]; sox32-MO, 59-CAGGGAG-
CATCCGGTCGAGATACAT-59 [38], smc3-MO, 59-GTACAT-
GGCGGTTTATGCACAAAAC-39 [31]; rad21-MO, 59- AGGAC-
GAAGTGGGCGTAAAACATTG-39 [32].
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buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca
(NCO3)2, 5 mM HEPES (pH 7.6)) and stored at 220uC. To
construct nipbla-59-UTR-EGFP and nipblb-59-UTR-EGFP report-
er genes, double stranded oligo DNAs encoding 59-UTR of nipbla
or nipblb containing target sites of MOs were fused with EGFP
cDNA by subcloning both into the pCS2+ vector. Full-length
cDNAs of gata5 and sox32 were amplified by RT-PCR and cloned
into pCS2+. sox32-9mis cDNA was prepared by RT-PCR using
the cloned sox32 cDNA as a template with primers designed to
introduce mutations within the sox32-MO target sequence located
at 59 end of ORF. Mutations in sox32-9mis are introduced within
the first 25 bases of ORF: ATGTActTgGAtaGaATGtTgCCaG
(mutations are shown in lower cases and do not change amino acid
sequence). Effective translation of sox32-9mis in the presence of
sox32-MO was examined by reporter assay using fusion reporter
constructs, in which the first 30 bases of sox32 and sox32-9mis ORF
was fused in frame with EGFP cDNA (Figure 5E). Capped mRNA
was synthesized using mMESSAGE mMACHINE kit (Ambion).
MOs and in vitro synthesized mRNA were injected into yolk of
embryos at the 1–4-cell stage.
Whole Mount In Situ Hybridization (ISH) and Northern
Blotting
Whole mount ISH was performed using digoxigenin (DIG)-
labeled antisense RNA probes [83]. For Northern blotting, total
RNA was prepared using TRIzol (Invitrogen). RNA (10 mg per
lane) was separated on formaldehyde gels, transferred to nylon
membranes, and probed with two different DIG-labeled antisense
RNA probes for nipbla and nipblb. Hybridized probes were detected
by using alkaline phosphate-conjugated anti-DIG antibody and
visualized with NBT/BCIP (Roche).
Western Blotting
Plasmids for expression of 6x-His-tagged fusions of amino acid
residues 523–948 of Nipbla and residues 232–593 of Nipblb
(corresponding to regions poorly conserved between the two
proteins) were constructed by subcloning partial cDNA fragments
of nipbla and nipblb into the pET15b vector. The proteins were
expressed in E. coli (Rosetta-gami2 [Novagen]), purified by nickel-
column chromatography, and used to immunize rabbits at Open
Biosystems, Inc. For Western blotting, total protein was extracted
from embryos as described [84]. Briefly, chorions were removed,
yolks punctured by pipetting in 1/26 Ginzburg Fish Ringer
without calcium (55 mM NaCl, 1.8 mM KCl, 1.25 mM
NaHCO3), and cells collected by centrifugation and lysed by
boiling in Laemmli buffer. Total protein (5–10 embryos per lane)
was separated by SDS-PAGE and subjected to Western blotting
with anti-Nipbla (1:1,000), anti-Nipblb (1:400), and anti-a-Tubulin
(Sigma, 1:2,000), and detected by chemiluminscence (SuperSignal,
Pierce). Protein levels were quantified using ImageJ software.
Quantitative RT-PCR (Q-PCR)
Gene expression was measured by Q-PCR using SYBR green and
analyzed using iQ5 and CFX software (BioRad). cDNA was
synthesized using Superscript III first strand synthesis (Invitrogen).
Alldatawerenormalizedtoef-1aasareference,andrpl13a[85]served
as a negative control for MO specificity (neither ef-1a nor rpl13a
transcript levels were altered in microarray analysis of nipbla/b-
morphants; unpublished data). At least three replicates were
examined for each primer set and data were averaged over three
independent experiments 6 S.E.M. p values were calculated from
DCtvaluesbypairedttest.PrimersforQ-PCRareshowninTableS1.
Microarray
RNA was prepared from 30–40 each of uninjected embryos or
embryos co-injected with 2 ng each of nipbla-MO1 and nipblb-
MO1. Total RNA was isolated at 6 hpf (Shield stage) using TRIzol
and further purified using the RNeasy kit (Qiagen). cRNA
preparation, hybridization, and scanning were done at the
microarray facility at the University of California, Irvine using
Affymetrix GeneChip Zebrafish Genome Arrays. Hybridization
was performed in triplicate using cRNA from three biologically
independent samples. Data were analyzed with Gene Pattern Web
software (http://www.broadinstitute.org/cancer/software/gene
pattern/), and ranked by permutation analysis.
Alcian Blue Staining
Embryos were fixed at 120 hpf and craniofacial cartilages were
visualized by staining with Alcian blue as described previously [86].
Supporting Information
Figure S1 Predicted amino acid sequences of zebrafish Nipbla
and Nipblb. Predicted amino acid sequences of zebrafish Nipbla
and Nipblb were aligned with human NIPBL (NP_597677).
Conserved identical and similar amino acids are shown in dark
and light purple, respectively. Predicted motifs, as shown in
Figure 1A, are in the colored boxes: Regions required for binding
to Scc4 (green), HP1 (red), and HDAC1 and 3 (blue), putative
nuclear localization signal (yellow), and HEAT domains (black).
(TIF)
Figure S2 Expression of nipbla and nipblb mRNAs during
development. Northern blot. Total RNA was prepared from
embryos at indicated stages and loaded at 10 mg per lane. mRNAs
were analyzed with DIG labeled antisense RNA probes (AS1 in
Figure 1A). ef-1a was used as a control. Expression level of ef-1a
was significantly increased after mid-blastula transition (3 hpf) as
reported [87]. Molecular weights are indicated on the right.
(EPS)
Figure S3 Activities of nipbl-MOs. To evaluate MO specificity, we
used two different MOs (MO1 and MO2) for each nipbl gene that
target non-over-lapping sequences within the 59-UTR, and used
Western blotting with anti-Nipbla and Nibplb antibodies to find the
minimum amount required for maximal knockdown. (A) Nipbla-
and Nipblb-specific antibodies were prepared and evaluated by
Western blotting using lysates of embryos at 10 hpf (10 embryos per
lane). Molecular weight markers are on the right. (B) Dose-
dependence of MO effects. nipbla-MO1 virtually eliminated Nipbla
protein at 0.5 ng/embryo (upper left). nipbla-MO2 only partially
suppressed Nipbla expression, even at 2–4 ng/embryo (lower left).
Nipblb protein was reduced by either of two nipblb-MOs at 0.25–
0.5 ng/embryo partially, but further reduction was not observed
with higher amounts of MOs (2 ng/embryo) (upper and lowerright).
(C) Effects of nipblb-MOs on Nipblb protein levels at 24 hpf. Nipblb
protein was significantly reduced by 0.5–1 ng/embryo of nipblb-
MO1andMO2at24hpf.(D)BothNipblaandNipblbproteinswere
reduced in embryos co-injected with 2 ng each of nipbla-MO1 and
nipblb-MO1 (nipbl-MOs), but not in uninjected embryos or embryos
co-injected with 2 ng each of 5mis-nipbla-MO1 and 5mis-nipblb-
MO1 (5mis-MOs). a-Tubulin is a loading control. Although 5mis-
MOs at 2 ng each/embryo had no effect on Nipbl levels, they did
cause delay of development after mid-somitogenesis (unpublished
data). Accordingly, given these results, the minimum effective
amounts of MOs were determined to be 0.5 ng/embryo (for nipbla-
MO1, nipblb-MO1, and nipblb-MO2) and 1 ng (for nipbla-MO2).
(EPS)
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Lateral views of tails (A, B) and anal regions (C, D) of controls and
nipbla/b-morphants at 52 hpf. Morphant tails are shortened and
branched along the dorsal-ventral axis (B). Some morphants (10%)
lack a urogenital opening (arrows in C and D). Scale bars: 50 mm.
(EPS)
Figure S5 Defects in the larval craniofacial skeleton in nipbla/b-
morphants. Craniofacial cartilages were stained with Alcian blue at
120 hpf. Controls (A, D, G) and two examples of nipbla/b-
morphants (B, C, E, F, H, I) are shown in ventral (A–C),
ventrolateral (D), and lateral view (E–I), anterior to the left. Specific
reductionsinhyosymplecticcartilages areindicatedbyarrows (D–F)
and outlined at higher magnification (G–I). Scale bar: 100 mm.
(TIF)
Figure S6 Effects of nipbls on heart development. Heart
morphology in nipbla/b-morphants at 48 hpf was examined by
the expression of cmlc2. Anterior views of control embryos (leftmost
panel) as well as nipbla/b-morphants with type A or type B heart
defects. White dotted lines outline the heart tubes and arrows
indicate split hearts in type B morphants. Scale bar: 50 mm.
(EPS)
Figure S7 Circulation defects and pericardial edema in the
nipbla/b-morphants. (A) Numbers of embryos with heart defects in
nipbla/b-MOs within each class that showed circulation defects or
pericardial edema at 32 hpf. (B–E) o-Dianisidine staining of
developed erythrocytes. Erythrocytes were stained by incubating
anesthetized living embryos in 10 mM sodium acetate, pH 4.5,
0.65% hydrogen peroxide, 40% ethanol, and 0.6 mg/ml of o-
dianisidine for 15 min at 28.5uC. Control embryos (B, C) and
nipbla/b-morphants with circulation defects (D, E) were stained
with o-dianisidine at 32 hpf. Ventral views of the heart (B, D) and
lateral views of the tail (C, E) are shown. In morphants,
erythrocytes accumulated ventrally (arrow head in E) including
the intermediate cell mass (ICM) (arrow in E), and yolk surface (D).
(F–I) gata1 (blood cells) (F, G; 20 hpf) and fli1a (blood vessels) (H, I;
31 hpf) expression were examined by ISH in controls (F, H) and
nipbla/b-morphants (G, I). Scale bars: 100 mm.
(EPS)
Figure S8 Effects of reduction of nipbls on endodermal and
Nodal-signaling genes. (A) Expression of endodermal genes (sox17,
foxa2, and gata5) was examined by ISH at 8.5 hpf. Expression of all
three was downregulated in endoderm (arrows) but not in dorsal
forerunner cells (sox17; arrowheads) or axial mesoderm (foxa2;
brackets). gata5 expression was mainly reduced dorsally (arrow). (B)
In contrast, no changes were observed in expression of the Nodal-
related gene, cyc, a Nodal receptor co-factor, oep, or a mesodermal
Nodal target, ntl,i nnipbla/b-morphants compared with controls at
6.5 hpf. Lateral views with dorsal to the right in all cases except
gata5, which is shown in dorsal view, anterior to the left. Scale bars:
50 mm. (C) Expression of endodermal and nonendodermal genes
were examined by Q-PCR at 7 hpf in controls (black) and nipbla/b-
morphants (red). Expression levels are normalized to that of ef-1a
and shown relative to values in control embryos. p values were
calculated by paired t test, using DCt values (n=4, mean 6
S.E.M., * p,0.002 and others are p.0.1).
(EPS)
Figure S9 Correlation between phenotypic variation and Nipbla
protein level. (A) Frequencies of gut/visceral organ morphologies
in nipbla/b-morphants, as examined by foxa3 expression at 52 hpf,
after live-sorting embryos at 32 hpf according to heart morphol-
ogy. (B–E) A series of diluted nipbla-MO1 (0.031–0.75 ng as
indicated) was coinjected with a fixed amount (0.75 ng) of nipblb-
MO1, and protein levels (B) as well as phenotypes (C–E) were
examined. (B) Protein levels were examined by Western blotting at
6.5 hpf (upper panels). Nipbla and Nipblb bands were quantified
using ImageJ, normalized to a-Tubulin, and plotted relative to
values in uninjected controls (n=4, mean 6 S.E.M). (C–E)
Frequencies of heart defects at 32 hpf (C), gut defects at 52 hpf (D),
and circulation and tail defects at 32 hpf (E).
(EPS)
Figure S10 Activity of sox17-MO. (A) Schematics of sox17 pre-
and mature mRNAs showing positions of the sox17-MO binding
site and primers used for RT-PCR. (B) Effectiveness of a splice-
blocking sox17-MO was examined by RT-PCR. cDNA from
uninjected embryos and embryos injected with 2.5 and 5 ng of
sox17-MO was prepared at 7 hpf and expression of pre- (a, c) and
mature- (b) sox17 mRNAs was examined by RT-PCR.
(EPS)
Figure S11 Effects of low amounts of smc3-MO on gene
expression. (A) Morphology of living embryos at 26 hpf. Lateral
views with anterior to the left. (B) Q-PCR analyses of gene
expression in uninjected control (black), nipbla/b-morphants (blue),
and low-smc3 (0.75 ng)-morphants (red) at 25 hpf by Q-PCR
(n=3, mean 6 S.E.M.; * p,0.05 and # p.0.1 by paired t test).
Scale bar: 100 mm.
(EPS)
Table S1 Primers used for Q-PCR.
(DOC)
Table S2 Phenotypes of nipbl-morphants.
(DOC)
Table S3 600 genes potentially down- or up-regulated in nipbla/
b-morphants.
(DOC)
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